Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
PRT811
i
Other names:
PRT-811, PRT811, PRT 811
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Prelude Therap
Drug class:
PRMT5 inhibitor
Related drugs:
‹
MRTX1719 (7)
AMG 193 (5)
TNG908 (3)
EPZ015666 (2)
PRT543 (2)
MRTX9768 (1)
TNG462 (1)
GSK3326595 (1)
AGX323 (0)
AT101 (0)
GSK591 (0)
LLY-283 (0)
PF-06939999 (0)
SIM0272 (0)
SKL27969 (0)
T1-44 (0)
UCT-000445 (0)
JNJ-64619178 (0)
MRTX1719 (7)
AMG 193 (5)
TNG908 (3)
EPZ015666 (2)
PRT543 (2)
MRTX9768 (1)
TNG462 (1)
GSK3326595 (1)
AGX323 (0)
AT101 (0)
GSK591 (0)
LLY-283 (0)
PF-06939999 (0)
SIM0272 (0)
SKL27969 (0)
T1-44 (0)
UCT-000445 (0)
JNJ-64619178 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
IDH2 mutation
Glioma
IDH2 mutation
Glioma
PRT811
Sensitive: C3 – Early Trials
PRT811
Sensitive
:
C3
PRT811
Sensitive: C3 – Early Trials
PRT811
Sensitive
:
C3
IDH1 mutation
Glioma
IDH1 mutation
Glioma
PRT811
Sensitive: C3 – Early Trials
PRT811
Sensitive
:
C3
PRT811
Sensitive: C3 – Early Trials
PRT811
Sensitive
:
C3
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation
Acute Myelogenous Leukemia
gilteritinib + PRT811
Sensitive: D – Preclinical
gilteritinib + PRT811
Sensitive
:
D
gilteritinib + PRT811
Sensitive: D – Preclinical
gilteritinib + PRT811
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login